IFC Holdings’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-900
Closed -$219K 537
2017
Q2
$219K Buy
+900
New +$211K 0.02% 441
2016
Q1
Sell
-2,686
Closed -$842K 414
2015
Q4
$842K Sell
2,686
-20,287
-88% -$6.04M 0.11% 137
2015
Q3
$6.41M Sell
22,973
-5
-0% -$1.54K 0.98% 20
2015
Q2
$7.05M Sell
22,978
-534
-2% -$159K 1.02% 19
2015
Q1
$7.13M Buy
23,512
+1,113
+5% +$317K 1.09% 18
2014
Q4
$5.76M Buy
22,399
+653
+3% +$163K 0.95% 18
2014
Q3
$5.24M Buy
21,746
+1,024
+5% +$229K 0.95% 19
2014
Q2
$4.63M Buy
20,722
+342
+2% +$70.8K 0.85% 21
2014
Q1
$4.16M Sell
20,380
-747
-4% -$148K 0.86% 22
2013
Q4
$3.5M Buy
21,127
+180
+0.9% +$28.1K 0.74% 29
2013
Q3
$3.02M Buy
20,947
+9
+0% +$1.2K 0.66% 30
2013
Q2
$2.64M Buy
+20,938
New +$2.37M 0.63% 32

Other funds holding AGN

IFC Holdings's AGN Position: Q3 2017 in Review

IFC Holdings sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 900 shares — an estimated $219K sold.

IFC Holdings first reported a position in AGN in Q2 2013 and held it in 12 quarters. The position peaked at $7.13M in Q1 2015. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • IFC Holdings reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • IFC Holdings sold 900 Allergan plc shares in Q3 2017, an estimated $219K.
  • IFC Holdings first reported a position in Allergan plc in Q2 2013 and held it in 12 quarters.
  • IFC Holdings's Allergan plc position peaked at $7.13M in Q1 2015.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on IFC Holdings's 13F filing for Q3 2017, filed 26 Oct 2017.